Artykuły w czasopismach na temat „Cancer papillaire de la thyroïde (PTC)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cancer papillaire de la thyroïde (PTC)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Nezzar, Adlen. "Molecular biology and thyroid cancer". Batna Journal of Medical Sciences (BJMS) 2, nr 1 (30.06.2015): 60–65. http://dx.doi.org/10.48087/bjmstf.2015.2114.
Pełny tekst źródłaShrestha, Rupendra T., Darin Ruanpeng i James V. Hennessey. "Cytomorphology of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and the Impact of New Nomenclature on Molecular Testing". Medical Sciences 7, nr 2 (22.01.2019): 15. http://dx.doi.org/10.3390/medsci7020015.
Pełny tekst źródłaLiu, Xiaoli, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K. El-Naggar i Mingzhao Xing. "Highly prevalent TERT promoter mutations in aggressive thyroid cancers". Endocrine-Related Cancer 20, nr 4 (13.06.2013): 603–10. http://dx.doi.org/10.1530/erc-13-0210.
Pełny tekst źródłaKrause, Kerstin, Stefan Karger, Oliver Gimm, Sien-Yi Sheu, Henning Dralle, Andrea Tannapfel, Kurt Werner Schmid, Corinne Dupuy i Dagmar Fuhrer. "Characterisation of DEHAL1 expression in thyroid pathologies". European Journal of Endocrinology 156, nr 3 (marzec 2007): 295–301. http://dx.doi.org/10.1530/eje-06-0596.
Pełny tekst źródłaOzmen, Hilal Kiziltunc, Seda Askin, Eda Simsek, Ayse Carlioglu, Şenay Arikan i Mustafa Utlu. "Mean Platelet Volume and Red Cell Distribution Width in Differentiated Thyroid Cancer Patients". Open Medicine Journal 6, nr 1 (20.12.2019): 94–100. http://dx.doi.org/10.2174/1874220301603010094.
Pełny tekst źródłaLanda, Iñigo. "Advances in Thyroid Carcinoma". Cancers 14, nr 12 (13.06.2022): 2908. http://dx.doi.org/10.3390/cancers14122908.
Pełny tekst źródłaSoni, H., J. Batra, S. Dhandayuthapani, A. Mishra i J. Aggarwal. "Genetic Polymorphism in Papillary Thyroid Cancerm j in North Indian Population – A review". CARDIOMETRY, nr 25 (14.02.2023): 1188–91. http://dx.doi.org/10.18137/cardiometry.2022.25.11881191.
Pełny tekst źródłaMartin, Sorina, Theodor Mustata, Oana Enache, Oana Ion, Andreea Chifulescu, Anca Sirbu, Carmen Barbu i in. "Platelet Activation and Inflammation in Patients with Papillary Thyroid Cancer". Diagnostics 11, nr 11 (22.10.2021): 1959. http://dx.doi.org/10.3390/diagnostics11111959.
Pełny tekst źródłaArican, Cigdem D., Tulin Ozturk, Muhammet Sait Sager, Ipek Sertbudak, Serkan Teksoz, Cansu Turker Saricoban i Abdulkerim Uygur. "Incidental Papillary Microcarcinoma and Papillary Thyroid Carcinoma in Multinodular Goiter". Analytical Cellular Pathology 2023 (14.01.2023): 1–7. http://dx.doi.org/10.1155/2023/2768344.
Pełny tekst źródłaTao, Ling, Li Yang, Ping Tian, Xiangyang Guo i Yanping Chen. "Knockdown of circPVT1 inhibits progression of papillary thyroid carcinoma by sponging miR-126". RSC Advances 9, nr 23 (2019): 13316–24. http://dx.doi.org/10.1039/c9ra01820d.
Pełny tekst źródłaDegl'Innocenti, Debora, Paola Romeo, Eva Tarantino, Marialuisa Sensi, Giuliana Cassinelli, Veronica Catalano, Cinzia Lanzi i in. "DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells". Endocrine-Related Cancer 20, nr 1 (6.11.2012): 23–37. http://dx.doi.org/10.1530/erc-12-0078.
Pełny tekst źródłaYun, Hyeok Jun, Minki Kim, Sang Yong Kim, Sungsoon Fang, Yonjung Kim, Hang-Seok Chang, Ho-Jin Chang i Ki Cheong Park. "Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer". International Journal of Molecular Sciences 23, nr 2 (9.01.2022): 699. http://dx.doi.org/10.3390/ijms23020699.
Pełny tekst źródłaRosario, Pedro Weslley, i Gabriela Franco Mourão. "Noninvasive Encapsulated Papillary RAS-Like Thyroid Tumor (NEPRAS)". Journal of the Endocrine Society 5, Supplement_1 (1.05.2021): A894. http://dx.doi.org/10.1210/jendso/bvab048.1825.
Pełny tekst źródłaYing, Tianxing, Xumeng Wang, Yunjin Yao, Jimeng Yuan, Shitu Chen, Liping Wen, Zhijian Chen i in. "Integrative Methylome and Transcriptome Characterization Identifies SERINC2 as a Tumor-Driven Gene for Papillary Thyroid Carcinoma". Cancers 15, nr 1 (30.12.2022): 243. http://dx.doi.org/10.3390/cancers15010243.
Pełny tekst źródłaRusinek, Dagmara, Sylwia Szpak-Ulczok i Barbara Jarzab. "Gene expression profile of human thyroid cancer in relation to its mutational status". Journal of Molecular Endocrinology 47, nr 3 (28.07.2011): R91—R103. http://dx.doi.org/10.1530/jme-11-0023.
Pełny tekst źródłaPanebianco, Federica, Alyaksandr V. Nikitski, Marina N. Nikiforova, Cihan Kaya, Linwah Yip, Vincenzo Condello, Abigail I. Wald, Yuri E. Nikiforov i Simion I. Chiosea. "Characterization of thyroid cancer driven by known and novel ALK fusions". Endocrine-Related Cancer 26, nr 11 (listopad 2019): 803–14. http://dx.doi.org/10.1530/erc-19-0325.
Pełny tekst źródłaJin, Meihua, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim i in. "Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas". Cancers 13, nr 4 (20.02.2021): 892. http://dx.doi.org/10.3390/cancers13040892.
Pełny tekst źródłaJoseph, Dr Liz Maria, i Dr Sankar S. "Papillary Thyroid Carcinoma with Lung Metastasis after 31 Years: A Case Report". East African Scholars Journal of Medical Sciences 5, nr 3 (13.03.2022): 84–87. http://dx.doi.org/10.36349/easms.2022.v05i03.002.
Pełny tekst źródłaSchlumberger, M. "Cancer papillaire et folliculaire de la thyroïde". Annales d'Endocrinologie 68, nr 2-3 (czerwiec 2007): 120–28. http://dx.doi.org/10.1016/j.ando.2007.04.004.
Pełny tekst źródłaWeng, Xun, YangYang i Yujiao Cai. "Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients". Disease Markers 2022 (31.01.2022): 1–8. http://dx.doi.org/10.1155/2022/5188006.
Pełny tekst źródładi Masi, Alessandra, Rosario Luigi Sessa, Ylenia Cerrato, Gianni Pastore, Barbara Guantario, Roberto Ambra, Michael Di Gioacchino i in. "Unraveling the Effects of Carotenoids Accumulation in Human Papillary Thyroid Carcinoma". Antioxidants 11, nr 8 (27.07.2022): 1463. http://dx.doi.org/10.3390/antiox11081463.
Pełny tekst źródłaMolvi, Ahad Yousaf, Qandila Ali, Ayesha Pervaiz, Muhammad Paras Naseem, Mubasher Ikram i Rahim Dhanani. "Total Laryngectomy in Advanced Papillary Thyroid Cancer Infiltrating into Larynx: A Case Report & review of Literature". National Journal of Health Sciences 7, nr 4 (30.12.2022): 196–98. http://dx.doi.org/10.21089/njhs.74.0196.
Pełny tekst źródłaLanda, Iñigo, Ian Ganly, Timothy A. Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A. Ghossein i James A. Fagin. "Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease". Journal of Clinical Endocrinology & Metabolism 98, nr 9 (1.09.2013): E1562—E1566. http://dx.doi.org/10.1210/jc.2013-2383.
Pełny tekst źródłaPoalelungi, Cătălina, Andra-Ileana Caragheorgheopol i Sorina Violeta Schipor. "CLINICAL VALUE OF GALECTIN-3 IN DIFFERENTIATING PAPILLARY THYROID CANCER FROM NODULAR GOITER". Romanian Archives of Microbiology and Immunology 81, nr 1 (31.03.2022): 21–26. http://dx.doi.org/10.54044/rami.2022.01.04.
Pełny tekst źródłaPallante, Pierlorenzo, Rosa Visone, Carlo Maria Croce i Alfredo Fusco. "Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas". Endocrine-Related Cancer 17, nr 1 (marzec 2010): F91—F104. http://dx.doi.org/10.1677/erc-09-0217.
Pełny tekst źródłaSahar, Abd ELmogheth Madani, i Gotsiridze Irine. "Study of BRAF and RAS Mutations in Thyroid Nodules with Indeterminate Cytology and Papillary Thyroid Cancer". Food Processing & Nutritional Science 1, nr 2 (31.12.2020): 105–12. http://dx.doi.org/10.46619/fpns.2020.1-1009.
Pełny tekst źródłaGao, Yun, Yi Pan, Tingting Wang, Ying Yao, Wenbo Yuan, Xue Zhu i Ke Wang. "MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization". Acta Biochimica et Biophysica Sinica 53, nr 12 (23.10.2021): 1650–61. http://dx.doi.org/10.1093/abbs/gmab147.
Pełny tekst źródłaDURMUŞ, Elif Tutku, Ayşegül ATMACA, Mehmet KEFELİ, Ramis ÇOLAK, Buğra DURMUŞ i Cafer POLAT. "Papillary thyroid carcinoma prevalence and its predictors in patients with primary hyperparathyroidism". Journal of Health Sciences and Medicine 5, nr 5 (25.09.2022): 1499–504. http://dx.doi.org/10.32322/jhsm.1152567.
Pełny tekst źródłaPerveen, Rahima, Jasmin Ferdous, Sharmin Quddus i Tapati Mandal. "Solitary Liver Metastasis from Follicular Variant Papillary Thyroid Carcinoma: A Case Report". Bangladesh Journal of Nuclear Medicine 22, nr 2 (1.02.2021): 146–49. http://dx.doi.org/10.3329/bjnm.v22i2.51768.
Pełny tekst źródłaPark, Jong-Lyul, Seon-Kyu Kim, Sora Jeon, Chan-Kwon Jung i Yong-Sung Kim. "MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer". Cancers 13, nr 4 (5.02.2021): 632. http://dx.doi.org/10.3390/cancers13040632.
Pełny tekst źródłaAïssaoui, R., Z. Turki, A. Achiche, M. H. Balti, C. Ben Slama i M. Zbiba. "Métastase surrénalienne d’un cancer papillaire de la thyroïde". Annales d'Endocrinologie 67, nr 4 (wrzesień 2006): 364–67. http://dx.doi.org/10.1016/s0003-4266(06)72614-2.
Pełny tekst źródłaUlisse, Salvatore, Enke Baldini, Augusto Lauro, Daniele Pironi, Domenico Tripodi, Eleonora Lori, Iulia Catalina Ferent i in. "Papillary Thyroid Cancer Prognosis: An Evolving Field". Cancers 13, nr 21 (7.11.2021): 5567. http://dx.doi.org/10.3390/cancers13215567.
Pełny tekst źródłaYang, Yang, Qin Chen, Wen-Ying Yu, Huan-Huan Zhang, Yu-Sen Zhong, Song-Zhao Zhang, Jia-Feng Wang i Chen-Huan Yu. "Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma". BioMed Research International 2020 (31.01.2020): 1–10. http://dx.doi.org/10.1155/2020/1340153.
Pełny tekst źródłaMazzaferri, Ernest L. "Thyroid Cancer - Changing Patterns of Diagnosis and Treatment". US Endocrinology 00, nr 01 (2005): 62. http://dx.doi.org/10.17925/use.2005.00.01.62.
Pełny tekst źródłaPalermo, Andrea, Andrea Napolitano, Daria Maggi, Anda Mihaela Naciu, Gaia Tabacco, Silvia Manfrini, Anna Crescenzi i in. "Regression of Papillary Thyroid Cancer during Nivolumab for Renal Cell Cancer". European Thyroid Journal 9, nr 3 (2020): 157–61. http://dx.doi.org/10.1159/000506107.
Pełny tekst źródłaRomei, Cristina, i Rossella Elisei. "A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer". International Journal of Molecular Sciences 22, nr 4 (9.02.2021): 1726. http://dx.doi.org/10.3390/ijms22041726.
Pełny tekst źródłaSondorp, Luc H. J., Vivian M. L. Ogundipe, Andries H. Groen, Wendy Kelder, Annelies Kemper, Thera P. Links, Robert P. Coppes i Schelto Kruijff. "Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening". Cancers 12, nr 11 (31.10.2020): 3212. http://dx.doi.org/10.3390/cancers12113212.
Pełny tekst źródłaLam, Alfred King-yin, i Nassim Saremi. "Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer". Endocrine-Related Cancer 24, nr 4 (kwiecień 2017): R109—R121. http://dx.doi.org/10.1530/erc-17-0014.
Pełny tekst źródłaGupta, Shalini, Aneeta Patel, Angela Folstad, Cydney Fenton, Catherine A. Dinauer, R. Michael Tuttle, Richard Conran i Gary L. Francis. "Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young Adults1". Journal of Clinical Endocrinology & Metabolism 86, nr 3 (1.03.2001): 1346–54. http://dx.doi.org/10.1210/jcem.86.3.7310.
Pełny tekst źródłaYin, De-tao, Wenxun Wu, Mingchuang Li, Qi-en Wang, Hongqiang Li, Yongfei Wang, Yifeng Tang i Mingzhao Xing. "DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma". Endocrine-Related Cancer 20, nr 4 (23.05.2013): 507–14. http://dx.doi.org/10.1530/erc-13-0053.
Pełny tekst źródłaRageh, Tarek M., Rehab M. Samaka, Mahmoud G. Hagag i Elsayed A. Motawa. "Relationship between focality and cervical lymph nodes metastasis in papillary thyroid carcinoma". International Surgery Journal 6, nr 2 (28.01.2019): 453. http://dx.doi.org/10.18203/2349-2902.isj20190079.
Pełny tekst źródłaSpourquet, Catherine, Ophélie Delcorte, Pascale Lemoine, Nicolas Dauguet, Axelle Loriot, Younes Achouri, Maija Hollmén i in. "BRAFV600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages". Cancers 14, nr 19 (26.09.2022): 4687. http://dx.doi.org/10.3390/cancers14194687.
Pełny tekst źródłaHitu, Cainap, Apostu, Gabora, Bonci, Badan, Mester i Piciu. "Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT". Diagnostics 10, nr 2 (12.02.2020): 100. http://dx.doi.org/10.3390/diagnostics10020100.
Pełny tekst źródłaVuong, Huy Gia, Ahmed MA Altibi, Uyen NP Duong, Hanh TT Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi i in. "Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis". Tumor Biology 39, nr 10 (październik 2017): 101042831771391. http://dx.doi.org/10.1177/1010428317713913.
Pełny tekst źródłaZhang, Hui-Min, Zi-Yi Li, Zhou-Tong Dai, Jun Wang, Le-Wei Li, Qi-Bei Zong, Jia-Peng Li, Tong-Cun Zhang i Xing-Hua Liao. "Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer". International Journal of Molecular Sciences 23, nr 19 (9.10.2022): 11989. http://dx.doi.org/10.3390/ijms231911989.
Pełny tekst źródłaReyes, Niradiz, Stephanie Figueroa, Christian Figueroa i Jan Geliebter. "Abstract 5020: Identification of transcriptional regulatory networks associated with papillary thyroid carcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 5020. http://dx.doi.org/10.1158/1538-7445.am2022-5020.
Pełny tekst źródłaStokowy, Tomasz, Danuta Gawel i Bartosz Wojtas. "Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants". International Journal of Endocrinology 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/1427042.
Pełny tekst źródłaSchultze, Maria Cecilia, Cintia Castro-Correia, Maria Bom-Sucesso i Marianne Becker. "Papillary thyroid carcinoma in a 7-year-old boy presenting with a goitre without microcalcifications and enlarged cervical lymph nodes". BMJ Case Reports 14, nr 7 (lipiec 2021): e242278. http://dx.doi.org/10.1136/bcr-2021-242278.
Pełny tekst źródłaKumar Baruah, Abir, Prasanta Kumar Baruah i Basanta Sonowal. "A CASE OF ENCAPSULATED TYPE OF FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA". International Journal of Advanced Research 10, nr 09 (30.09.2022): 831–36. http://dx.doi.org/10.21474/ijar01/15427.
Pełny tekst źródłade Raphélis Soissan, A., P. Berlier, L. Claude, C. Carrie i D. Frappaz. "Cancer papillaire de la thyroïde : second cancer après un rétinoblastome". Archives de Pédiatrie 19, nr 10 (październik 2012): 1086–88. http://dx.doi.org/10.1016/j.arcped.2012.07.007.
Pełny tekst źródła